Search research articles
Contact Us
Filters
Showing results (451-460 of 514) with videos related to
Page
of 52
Sort By:
Infection Control and Hospital Epidemiology
|
February 22, 2019
Diagnostic stewardship of C. difficile testing: a quasi-experimental antimicrobial stewardship study
Alyssa B Christensen, Viktorija O Barr, David W Martin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 24, 2006
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis
Prajnan Das, Edward H Lin, Sumita Bhatia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2006
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
Jean-Nicolas Vauthey, Timothy M Pawlik, Dario Ribero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 12, 2014
Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial
Paulo M Hoff, Daniel F Saragiotto, Carlos H Barrios, et al.
Cancers
|
December 16, 2020
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy
Franciele H Knebel, Louise J Barber, Alice Newey, et al.
Infection Control and Hospital Epidemiology
|
June 7, 2013
Infection related to implantable central venous access devices in cancer patients: epidemiology and risk factors
Maristela P Freire, Ligia C Pierrotti, Antônio E Zerati, et al.
British Journal of Cancer
|
December 24, 2014
Association between KRAS mutation and lung metastasis in advanced colorectal cancer
A A L Pereira, J F M Rego, V Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2009
Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance
Scott Kopetz, Paulo M Hoff, Jeffrey S Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2005
Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis
Julien Dômont, Timothy M Pawlik, Valérie Boige, et al.
American Journal of Clinical Oncology
|
June 7, 2006
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer
Prajnan Das, John M Skibber, Miguel A Rodriguez-Bigas, et al.
Page
of 52
Search research articles
Search
Showing results (451-460 of 514) with videos related to
Sort By:
Page
of 52
Infection Control and Hospital Epidemiology
|
February 22, 2019
Diagnostic stewardship of C. difficile testing: a quasi-experimental antimicrobial stewardship study
Alyssa B Christensen, Viktorija O Barr, David W Martin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 24, 2006
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis
Prajnan Das, Edward H Lin, Sumita Bhatia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2006
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
Jean-Nicolas Vauthey, Timothy M Pawlik, Dario Ribero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 12, 2014
Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial
Paulo M Hoff, Daniel F Saragiotto, Carlos H Barrios, et al.
Cancers
|
December 16, 2020
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy
Franciele H Knebel, Louise J Barber, Alice Newey, et al.
Infection Control and Hospital Epidemiology
|
June 7, 2013
Infection related to implantable central venous access devices in cancer patients: epidemiology and risk factors
Maristela P Freire, Ligia C Pierrotti, Antônio E Zerati, et al.
British Journal of Cancer
|
December 24, 2014
Association between KRAS mutation and lung metastasis in advanced colorectal cancer
A A L Pereira, J F M Rego, V Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2009
Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance
Scott Kopetz, Paulo M Hoff, Jeffrey S Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2005
Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis
Julien Dômont, Timothy M Pawlik, Valérie Boige, et al.
American Journal of Clinical Oncology
|
June 7, 2006
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer
Prajnan Das, John M Skibber, Miguel A Rodriguez-Bigas, et al.
Page
of 52